Skip to main content

Advertisement

SpringerLink
Log in

Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment

  • Sarcoma (SH Okuno, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Epithelioid hemangioendothelioma (EHE) is an extremely rare sarcoma, as such it can pose a clinical dilemma based solely on its rarity. Also, the spectrum of disease varies greatly between an indolent disease and aggressive disease with widespread metastases. In our clinical practice, the primary focus has been to get a handle on the aggressive nature of the disease, which will then dictate how urgently one needs to treat the patient. Pathological review with immunohistochemistry and molecular characterization is paramount. Our treatment strategy is watch-and-wait versus active therapy on clinical trial or based on results of prior clinical trials. There is evidence to support the use of chemotherapeutics and targeted therapies specifically focusing on anti-angiogenesis. The current landscape of oncology with the emergence and excitement of immunotherapy could also translate in a role for immunotherapy in this disease. While rare, there is certainly no reason that research and trials for patients with EHE should not remain on utmost importance for those of us who specialize in the treatment of sarcomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance, •• Of major importance

  1. Sardaro A, Bardoscia L, Petruzzelli MF, Portaluri M. Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor. Oncol Rev. 2014;8(2):259.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982;50(5):970–81.

    Article  CAS  PubMed  Google Scholar 

  3. Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, et al. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med. 2011;3(98):98ra82.

    Article  PubMed  Google Scholar 

  4. Doyle LA. Sarcoma classification: an update based on the 2013 World Health Organization classification of tumors of soft tissue and bone. Cancer. 2014;120(12):1763–74.

    Article  PubMed  Google Scholar 

  5. Amin RMS, Hiroshima K, Kokubo T, Nishikawa M, Narita M, Kuroki M, et al. Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report. Respirology. 2006;11(6):818–25.

    Article  PubMed  Google Scholar 

  6. Lau K, Massad M, Pollak C, Rubin C, Yeh J, Wang J, et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest. 2011;140(5):1312–8.

    Article  PubMed  Google Scholar 

  7. Kitaichi M, Nagai S, Nishimura K, Itoh H, Asamoto H, Izumi T, et al. Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. Eur Respir J. 1998;12(1):89–96.

    Article  CAS  PubMed  Google Scholar 

  8. Bagan P, Hassan M, Le Pimpec BF, Peyrard S, Souilamas R, Danel C, et al. Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: a review of the literature. Ann Thorac Surg. 2006;82(6):2010–3.

    Article  PubMed  Google Scholar 

  9. Gómez-Arellano LI, Ferrari-Carballo T, Domínguez-Malagón HR. Multicentric epithelioid hemangioendothelioma of bone. Report of a case with radiologic-pathologic correlation. Ann Diagn Pathol. 2012;16(1):43–7.

    Article  PubMed  Google Scholar 

  10. Larochelle O, Perigny M, Lagace R, Dion N, Giguere C. Best cases from the AFIP: epithelioid hemangioendothelioma of bone. Radiographics : a review publication of the Radiological Society of North America, Inc. 2006;26(1):265–70.

    Article  Google Scholar 

  11. Albakr A, Schell M, Drew B, Cenic A. Epithelioid hemangioendothelioma of the spine: Case report and review of the literature. J Spine Surg. 2017;3(2):250–9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ma J, Wang L, Mo W, Yang X, Xiao J. Epithelioid hemangioendotheliomas of the spine: clinical characters with middle and long-term follow-up under surgical treatments. Eur Spine J. 2011;20(8):1371–6.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Woo JH, Kim TJ, Lee KS, Kim TS, Kim BT. Epithelioid hemangioendothelioma in the thorax: clinicopathologic, CT, PET, and prognostic features. Medicine (Baltimore). 2016;95(30):e4348.

    Article  CAS  Google Scholar 

  14. Gan LU, Chang R, Jin H, Yang LI. Typical CT and MRI signs of hepatic epithelioid hemangioendothelioma. Oncol Lett. 2016;11(3):1699–706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Errani C, Zhang L, Panicek DM, Healey JH, Antonescu CR. Epithelioid hemangioma of bone and soft tissue: a reappraisal of a controversial entity. Clin Orthop Relat Res. 2012;470(5):1498–506.

    Article  PubMed  Google Scholar 

  16. Rosengarten D, Kramer MR, Amir G, Fuks L, Berkman N. Pulmonary epithelioid hemangioendothelioma. Isr Med Assoc J: IMAJ. 2011;13(11):676–9.

    PubMed  Google Scholar 

  17. Deyrup AT, Tighiouart M, Montag AG, Weiss SW. Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol. 2008;32(6):924–7.

    Article  PubMed  Google Scholar 

  18. Flucke U, Vogels RJ, de Saint Aubain Somerhausen N, Creytens DH, Riedl RG, van Gorp JM, et al. Epithelioid hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases. Diagnostic Pathology. 2014;9(1):131.

    Article  PubMed  PubMed Central  Google Scholar 

  19. •• Anderson T, Zhang L, Hameed M, Rusch V, Travis WD, Antonescu CR. Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions. Am J Surg Pathol. 2015;39(1):132–9. This large series which included 52 patients help us better understand the pathology and molecular profile of these rare tumors

    Article  PubMed  PubMed Central  Google Scholar 

  20. Murali R, Zarka MA, Ocal IT, Tazelaar HD. Cytologic features of epithelioid hemangioendothelioma. Am J Clin Pathol. 2011;136(5):739–46.

    Article  PubMed  Google Scholar 

  21. Gill R, O'Donnell RJ, Horvai A. Utility of immunohistochemistry for endothelial markers in distinguishing epithelioid hemangioendothelioma from carcinoma metastatic to bone. Arch Pathol Lab Med. 2009;133(6):967–72.

    CAS  PubMed  Google Scholar 

  22. Errani C, Zhang L, Shao SY, Hajdu M, Singer S, Maki RG, et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosom Cancer. 2011;50(8):644–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Tanas MR, Ma S, Jadaan FO, Ng CKY, Weigelt B, Reis-Filho JS, et al. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein. Oncogene. 2015;35:929.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Thway K, Mentzel T, Perrett CM, Calonje E. Multicentric visceral epithelioid hemangioendothelioma, with extremity dermal deposits, unusual late recurrence on the nasal bridge and TFE3 gene rearrangement. Hum Pathol 2017.

  25. Doyle LA, Fletcher CD, Hornick JL. Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics. Am J Surg Pathol. 2016;40(1):94–102.

    Article  PubMed  Google Scholar 

  26. Antonescu CR, Le Loarer F, Mosquera J-M, Sboner A, Zhang L, Chen C-L, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosom Cancer. 2013;52(8):775–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lee SJ, Yang WI, Chung WS, Kim SK. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements. Oncotarget. 2016;7(7):7480–8.

    PubMed  PubMed Central  Google Scholar 

  28. Kanemura S, Kuribayashi K, Moriya Y, Shimizu S, Tsujimura T, Nakano T. Pemetrexed for epithelioid haemangioendothelioma of the pleura. Respirol Case Rep. 2016;4(6):e00191.

    PubMed  PubMed Central  Google Scholar 

  29. Pinet C, Magnan A, Garbe L, Payan MJ, Vervloet D. Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy. Eur Respir J. 1999;14(1):237.

    Article  CAS  PubMed  Google Scholar 

  30. Merikas E, Grapsa D, Dikoudi E, Gkiozos I, Boura P, Charpidou A, et al. Epithelioid hemangioendothelioma treated with bevacizumab: a case series. Cancer Treat Commun. 2015;4(Supplement C):59–64.

    Article  Google Scholar 

  31. Gaur S, Torabi A, O’Neill TJ. Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report. Cancer Biol Med. 2012;9(2):133–6.

    PubMed  PubMed Central  Google Scholar 

  32. Belmont L, Zemoura L, Couderc LJ. Pulmonary epithelioid haemangioendothelioma and bevacizumab. J Thoracic Oncol : Off Publ Int Assoc Study Lung Cancer. 2008;3(5):557–8.

    Article  Google Scholar 

  33. Kim YH, Mishima M, Miyagawa-Hayashino A. Treatment of pulmonary epithelioid hemangioendothelioma with bevacizumab. J Thorac Oncology: Off Publ Int Assoc Study Lung Cancer. 2010;5(7):1107–8.

    Article  Google Scholar 

  34. Mizota A, Shitara K, Fukui T. Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea. J Thorac Oncol : Off Publ Int Assoc Study Lung Cancer. 2011;6(3):651–2.

    Article  Google Scholar 

  35. Lau A, Malangone S, Green M, Badari A, Clarke K, Elquza E. Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma. Ther Adv Med Oncol. 2015;7(4):229–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Salech F, Valderrama S, Nervi B, Rodriguez JC, Oksenberg D, Koch A, et al. Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up. Ann Hepatol. 2011;10(1):99–102.

    CAS  PubMed  Google Scholar 

  37. Mascarenhas RC, Sanghvi AN, Friedlander L, Geyer SJ, Beasley HS, Van Thiel DH. Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology. 2004;67(5–6):471–5.

    Article  PubMed  Google Scholar 

  38. Raphael C, Hudson E, Williams L, Lester JF, Savage PM. Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report. J Med Case Rep. 2010;4:413.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Kassam A, Mandel K. Metastatic hepatic epithelioid hemangioendothelioma in a teenage girl. J Pediatr Hematol Oncol. 2008;30(7):550–2.

    Article  PubMed  Google Scholar 

  40. Bolke E, Gripp S, Peiper M, Budach W, Schwarz A, Orth K, et al. Multifocal epithelioid hemangioendothelioma: case report of a clinical chamaeleon. Eur J Med Res. 2006;11(11):462–6.

    PubMed  Google Scholar 

  41. Pallotti MC, Nannini M, Agostinelli C, Leoni S, Scioscio VD, Mandrioli A, et al. Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma. World J Gastroenterol: WJG. 2014;20(22):7049–54.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Zheng Z, Wang H, Jiang H, Chen E, Zhang J, Xie X. Apatinib for the treatment of pulmonary epithelioid hemangioendothelioma: a case report and literature review. Medicine. 2017;96(45):e8507.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Kobayashi N, Shimamura T, Tokuhisa M, Goto A, Ichikawa Y. Sorafenib monotherapy in a patient with Unresectable hepatic epithelioid Hemangioendothelioma. Case Rep Oncol. 2016;9(1):134–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. • Semenisty V, Naroditsky I, Keidar Z, Bar-Sela G. Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options. BMC Cancer. 2015;15:402. Although only a case report, this paper provides a review of antiangiogenic agents for the treatment of this disease

    Article  PubMed  PubMed Central  Google Scholar 

  45. Mao X, Liang Z, Chibhabha F, Ou W, Li N, Xu P, et al. Clinico-radiological features and next generation sequencing of pulmonary epithelioid hemangioendothelioma: a case report and review of literature. Thorac Cancer. 2017;8(6):687–92.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Lerut JP, Orlando G, Adam R, Schiavo M, Klempnauer J, Mirza D, et al. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry. Ann Surg. 2007;246(6):949–57. discussion 57

    Article  PubMed  Google Scholar 

  47. Agrawal N, Parajuli S, Zhao P, Satoskar R, Laurin J, Azumi N, et al. Liver transplantation in the management of hepatic epithelioid hemangioendothelioma: a single-center experience and review of the literature. Transplant Proc. 2011;43(7):2647–50.

    Article  CAS  PubMed  Google Scholar 

  48. Fang C, Zhang W, Zheng S. Liver transplantation for hepatic epithelioidhemangioendothelioma: a casereport and literature review. Int J Clin Exp Med. 2017;10(6):9693–6.

    Google Scholar 

  49. Saste A, Cabrera Fernandez DF, Gulati R, Gamalski S. A trimodality approach in the management of metastatic low-grade epithelioid hemangioendothelioma of the bone. BMJ Case Rep 2015;2015.

  50. Stacchiotti S, Provenzano S, Dagrada G, Negri T, Brich S, Basso U, et al. Sirolimus in advanced epithelioid hemangioendothelioma: a retrospective case-series analysis from the Italian rare cancer network database. Ann Surg Oncol. 2016;23(9):2735–44.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Northwestern University, Feinberg School of Medicine, 676 North Saint Clair, Suite 850, Chicago, IL, 60611, USA

    Ari Rosenberg MD & Mark Agulnik MD

Authors
  1. Ari Rosenberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Agulnik MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Agulnik MD.

Ethics declarations

Conflict of Interest

Ari Rosenberg and Mark Agulnik declare they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Sarcoma

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rosenberg, A., Agulnik, M. Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment. Curr. Treat. Options in Oncol. 19, 19 (2018). https://doi.org/10.1007/s11864-018-0536-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11864-018-0536-y

Keywords

Search

Navigation